Results 11 to 20 of about 13,716 (256)

Symmetrical drug‐related intertriginous and flexural exanthema‐like eruption after COVID‐19 vaccine

open access: yesJournal of the European Academy of Dermatology and Venereology, 2022
var-iant of BS referred as symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). report two cases of SDRIFE-like eruption occurring after COVID-19 vaccine.
I. Lahouel   +7 more
semanticscholar   +1 more source

Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006–2020

open access: yesViruses, 2021
Hand, foot, and mouth disease (HFMD) is a mild illness caused by enteroviruses (EV), although in some Asian countries, large outbreaks have been reported in the last 25 years, with a considerable incidence of neurological complications.
Nieves Martínez-López   +12 more
doaj   +1 more source

Symmetric drug‐related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature

open access: yesJournal of cutaneous pathology, 2021
Symmetric drug‐related intertriginous and flexural exanthema (SDRIFE) is a cutaneous drug reaction characterized by gluteal/anogenital erythema and symmetric involvement of other intertriginous location(s) without systemic signs.
A. Schuler   +7 more
semanticscholar   +1 more source

Symmetrical drug‐related intertriginous and flexural exanthema like eruption associated with COVID‐19 vaccination

open access: yesClincal and Experimental Dermatology, 2021
This is a case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption following ChAdOx1 nCoV‐19 (AstraZeneca‐Oxford) vaccination. Investigations, including repeated skin swabs, ruled out an infectious cause.
P. N. Lim, G. Wylie
semanticscholar   +1 more source

Allergic Signature in Delayed Cross-Hypersensitivity to all Iodinated Contrast Media. [PDF]

open access: yesAllergy
Allergy, Volume 80, Issue 11, Page 3178-3180, November 2025.
Do D   +13 more
europepmc   +2 more sources

Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2021
Coronavirus disease‐2019 (COVID‐19) has been associated with cutaneous findings, some being the result of drug hypersensitivity reactions such as maculopapular drug rashes (MDR).
Y. Mitamura   +18 more
semanticscholar   +1 more source

Epidemiological aspects of enterovirus infection in the Russian Federation during the period of 2018–2019

open access: yesЖурнал инфектологии, 2021
Aim: Analysis of enterovirus infection morbidity and characteristics of the etiological agents of this infection on some territories of Russia in 2017.Materials and methods: We investigated 7858 samples of the biological material from the patients ...
N. I. Romanenkova   +7 more
doaj   +1 more source

Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective

open access: yesVaccines, 2021
(1) Background: Numerous vaccines are under preclinical and clinical development for prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In light of high efficacy rates and satisfactory safety profiles, some agents have
Dennis Niebel   +7 more
doaj   +1 more source

Equine Coital Exanthema: New Insights on the Knowledge and Leading Perspectives for Treatment and Prevention

open access: yesPathogens, 2021
Equine coital exanthema (ECE) is a highly contagious, venereally-transmitted mucocutaneous disease, characterized by the formation of papules, vesicles, pustules and ulcers on the external genital organs of mares and stallions, and caused by equid ...
M. A. Vissani   +2 more
semanticscholar   +1 more source

Challenges in diagnostic research of multisystem inflammatory syndrome in children associated with COVID-19 in combination with the early stage of Epstein-Barr virus infection

open access: yesДетские инфекции (Москва), 2022
Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 is a rare life-threatening immunopathological complication of COVID-19 that develops 1-6 weeks after the acute coronavirus infection.
Е. А. Kashirina   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy